FdaApplication
ANDA 202659
Identifiers
- fda_app_no: ANDA202659
Properties
| Property | Value |
|---|---|
| applicant_name | HETERO LABS LTD UNIT V |
| application_type | ANDA |
| approval_date | 2018-06-11 |
Products (3)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| SILDENAFIL CITRATE | SILDENAFIL CITRATE | EQ 25MG BASE | TABLET;ORAL |
| SILDENAFIL CITRATE | SILDENAFIL CITRATE | EQ 100MG BASE | TABLET;ORAL |
| SILDENAFIL CITRATE | SILDENAFIL CITRATE | EQ 50MG BASE | TABLET;ORAL |
3 products